PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Aeterna Zentaris Inc (AEZS)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

CA0079754028

CUSIP

007975105

Sector

Healthcare

IPO Date

Jul 18, 1996

Highlights

Market Cap

$17.51M

EPS (TTM)

-$2.31

Total Revenue (TTM)

$4.39M

Gross Profit (TTM)

$1.66M

EBITDA (TTM)

-$6.04M

Year Range

$3.96 - $11.10

Target Price

$15.00

Short %

0.53%

Short Ratio

0.37

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Aeterna Zentaris Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%0.00%100.00%200.00%300.00%Jun 30Jul 07Jul 14Jul 21Jul 28Aug 04Aug 11Aug 18Aug 25September
-100.00%
291.05%
AEZS (Aeterna Zentaris Inc)
Benchmark (^GSPC)

Returns By Period


AEZS

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

25.18%

1M

-0.47%

6M

9.35%

1Y

24.83%

5Y*

13.03%

10Y*

11.14%

*Annualized

Monthly Returns

The table below presents the monthly returns of AEZS, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20240.54%2.14%14.66%-10.96%24.23%-54.39%31.22%5.86%-17.47%
202320.44%-15.14%-19.38%20.23%-11.90%-7.21%16.89%-13.59%-3.88%-39.88%31.73%-6.06%-41.51%
20221.32%0.28%1.83%-17.11%-32.23%-4.70%-10.97%4.56%-16.28%7.03%-4.48%-18.88%-64.20%
202161.27%70.50%-2.56%-7.02%-16.59%-0.81%-16.75%-1.37%4.17%-21.00%-19.80%-25.23%-16.50%
202017.03%-24.88%-36.00%50.39%50.65%-30.86%-41.46%-0.32%-25.00%-10.97%27.74%6.59%-53.24%
201930.27%3.66%17.13%-14.41%-24.62%-1.67%-15.25%-10.40%-54.02%-1.53%-11.26%1.11%-69.05%
2018-8.47%-17.13%-18.44%13.41%43.13%-17.72%-8.72%2.25%-4.40%25.29%55.05%-13.02%24.58%
2017-12.50%-3.17%-1.64%11.67%-66.87%-9.91%100.00%-2.50%4.10%-6.40%5.79%17.41%-34.44%
2016-27.46%-8.92%12.16%21.99%-15.80%-4.40%3.37%7.12%-4.71%11.92%-11.69%5.88%-19.64%
2015-11.67%22.26%-17.25%4.44%-47.68%-4.10%-35.37%-50.72%-1.68%-51.70%128.24%-53.81%-92.53%
2014-7.97%-1.57%-6.40%-2.56%-4.39%6.51%1.64%27.12%-10.67%-16.42%-53.57%15.38%-56.52%
201320.17%-15.73%-21.99%-3.19%13.74%-10.14%-24.73%5.00%2.72%-10.60%-14.81%20.00%-42.02%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of AEZS is 13, meaning it’s performing worse than 87% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of AEZS is 1313
Overall Rank
The Sharpe Ratio Rank of AEZS is 1313
Sharpe Ratio Rank
The Sortino Ratio Rank of AEZS is 1313
Sortino Ratio Rank
The Omega Ratio Rank of AEZS is 1414
Omega Ratio Rank
The Calmar Ratio Rank of AEZS is 1717
Calmar Ratio Rank
The Martin Ratio Rank of AEZS is 99
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Aeterna Zentaris Inc (AEZS) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
No data
AEZS
^GSPC

There is not enough data available to calculate the Sharpe ratio for Aeterna Zentaris Inc. We calculate this metric based on the past 12 months of trading data. Please check back later for updated information.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.502.002.50Jun 30Jul 07Jul 14Jul 21Jul 28Aug 04Aug 11Aug 18Aug 25September
-0.61
1.66
AEZS (Aeterna Zentaris Inc)
Benchmark (^GSPC)

Dividends

Dividend History


Aeterna Zentaris Inc doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%Jun 30Jul 07Jul 14Jul 21Jul 28Aug 04Aug 11Aug 18Aug 25September
-100.00%
-4.57%
AEZS (Aeterna Zentaris Inc)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Aeterna Zentaris Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Aeterna Zentaris Inc was 100.00%, occurring on Jul 2, 2024. The portfolio has not yet recovered.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-100%Jun 19, 20005950Jul 2, 2024
-25.58%May 18, 20006May 26, 200011Jun 16, 200017
-8.24%May 11, 20001May 11, 20003May 17, 20004

Volatility

Volatility Chart

The current Aeterna Zentaris Inc volatility is 18.06%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%Jun 30Jul 07Jul 14Jul 21Jul 28Aug 04Aug 11Aug 18Aug 25September
18.06%
4.88%
AEZS (Aeterna Zentaris Inc)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Aeterna Zentaris Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Aeterna Zentaris Inc.


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab